共 50 条
- [31] Influence of prostate volume and percent free prostate specific antigen on prostate cancer detection in men with a total prostate specific antigen of 2.6 to 10.0 ng/mlJOURNAL OF UROLOGY, 2007, 177 (05): : 1741 - 1744Bruno, J. James, IIArmenakas, Noel A.Fracchia, John A.
- [32] Prostate cancer detection free survival rates in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/ml in a single institution for 10 yearsINTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 179 - 179Yu, J.Kang, M.Sung, H. H.Jeon, H. G.Jeong, B. C.Seo, S. I.Lee, H. M.Soo, J. S.
- [33] Complexed prostate-specific antigen, and complext prostate-specific antigen indices for early detection of prostate cancer in men with total prostate-specific antigen between 2.0 and 4.0 ng/mlJOURNAL OF UROLOGY, 2003, 169 (04): : 426 - 427Reissigl, ARemzi, MWiunig, CZlotta, ARavery, VHammerer, PDobronski, PKaisary, AMarberger, MDjavan, B
- [34] Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4-10 ng/mL and negative digital rectal examinationPROSTATE INTERNATIONAL, 2018, 6 (04) : 136 - 139Sriplakich, SuponLojanapiwat, BannakijChongruksut, WilaiwanPhuriyaphan, SiwatKitirattakarn, PruitJun-Ou, JakritAmantakul, Akara
- [35] Detection of prostate cancer in men with prostate-specific antigen (PSA) levels of 2.0 to 4.0ng/ml is equivalent to that in men with 4.1 to 10.0ng/ml in a Japanese populationJOURNAL OF UROLOGY, 2004, 171 (04): : 478 - 479Kobayashi, TNishizawa, KMitsumori, KOgura, KIde, Y
- [36] Percent decrease of serum prostate-specific antigen after dutasteride administration is equivalent in men with clinical benign prostatic hyperplasia having baseline prostate-specific antigen >10 ng/mL and those having baseline prostate-specific antigen 2.5-10 ng/mLINTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (03) : 238 - 239Takeshita, HidekiKawakami, SatoruYano, AkihiroOkada, YoheiMorozumi, MakotoYamada, Takumi
- [37] Radical prostatectomy for prostate cancer patients with prostate-specific antigen >20 ng/mlJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 574 - 579Ou, YCChen, JTCheng, CLHo, HCYang, CR
- [38] Prospective study on the performance of the prostate-specific antigen isoform P2PSA and its derivative prostate health index in prediction of prostate cancer in local Chinese men with total prostate-specific antigen levels of 410 ng/mLINTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 62 - 62Tsang, Chiu-FungYiu, Ming KwongCheung, Fu-KeungChiu, YiHo, Brian Sze-HoNg, Ada Tsui-LinWong, Jason Ka-WingWong, Charles Kam-WaiPoon, Vincent Yick-KwanMa, Wai-KitTsu, James Hok-Leung
- [39] Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigenJOURNAL OF UROLOGY, 2004, 171 (06): : 2239 - 2244Catalona, WJBartsch, GRittenhouse, HGEvans, CLLinton, HJHorninger, WKlocker, HMikolajczyk, SD